ITguy
New member
- Awards
- 0
This is a follow up to a previous thread that I started concerning adding in DHEA while on an superdrol cycle to provide some product for eventual aromatization to estradial and thus potentially prevent the severe estrogen deficiency while ON superdrol and reduce the chances of any form of on cycle estrogen receptor upregulation which has been theorized as 1 of the potential culprits for gyno and delayed gyno following test subject superdrol cycles.
My test rats were already in the gyno prone category and followed the following cycle.
superdrol- weeks 1-4 10/15/20/20
DHEA----- weeks 1-4 0/75/75/100 (I used a low daily DHEA dose, you could test going higher, I also did not supplement subjects with DHEA for the 1st week just because I assumed that estrogens would not have been eliminated yet.)
post cycle therapy is as follows:
--DHEA- days 1-3 100/75/75 (I phased out the DHEA after 3 days because the thinking was that as the superdrol leaves the test rat's systems and the clomid and Toremifene kick in, product for natural aromatization to estrogen (testosterone)should be available and now the focus is moving towards minimizing estrogen and keep it from going too high as the Test to Est ratio is probably poor. Many subjects have used DHEA throughout post cycle therapy in low doses to potentially aid in maintaining gains through post cycle therapy, but this study was to focus on gyno prevention in already gyno prone rats.
--Daily Fenu caps --------------- weeks 1-5 1/2/2/2/2 (every other day for week 5)
--Daily Oats/Nettle/Ginseng caps- weeks 1-5 1/2/2/2/2 (every other day for week 5 on opposite days of Fenu)
--Clomid----- days 1-4 50mg/day
--Toremifene- days 1-4 90mg/day (Rat nuts back to full size by day 6; other studies state rat nuts back to full size quicker with higher Tore doses)
--Toremifene- days 5-10 60mg/day
--Toremifene- days 11-14 30mg/day
--Nolva------ days 15-18 10mg/day (ALERT! On day 16 test subject showed slight nipple tenderness which for many is the beginning of gyno. 30mg Tore added on days 16 and 17 and Nolva immediately increased to 20mg until day 21. (Presumed cause is tapering down the already low Tore dose too fast combined with underdosing the Nolva when converting from Tore to Nolva)
-1 daily cap of Rebound XT ATD was pulled in and added on day 16 as opposed to the end of post cycle therapy due to pre gyno side effects. All side effects completely resolved by day 18.
--Nolva-- days 16-21 20mg/day
--Nolva-- days 22-28 10mg/day
--RXT--- days 16-28 1 cap/day
Subjects currently in week 5 of post cycle therapy
--Nolva-------- week 5 5mg/day
--RXT--------- week 5 1 cap/every other day
--Fenu-------- week 5 2 caps/every other day.
--Oat complex- week 5 2 caps/every other day on opposite days as fenu.
Current Study Results:
--Gram weight before cycle----------- 165gms (lbs)
--Peak gram weight at end of cycle--- 178gms (lbs)
--Current gram weight at week 5 PCT- 172gms (lbs)
Additional Notes:
--Subject body types: long thin frames, extreme ecto/slight meso, high metabolism and naturally low body fat.
--Subjects diligently given protein shakes before bed every night and upon wakening and always try to maintain positive nitrogen balance during the day and night.
--Subjects have been unable to workout regularly during PCT but have still maintained gains well.
My test rats were already in the gyno prone category and followed the following cycle.
superdrol- weeks 1-4 10/15/20/20
DHEA----- weeks 1-4 0/75/75/100 (I used a low daily DHEA dose, you could test going higher, I also did not supplement subjects with DHEA for the 1st week just because I assumed that estrogens would not have been eliminated yet.)
post cycle therapy is as follows:
--DHEA- days 1-3 100/75/75 (I phased out the DHEA after 3 days because the thinking was that as the superdrol leaves the test rat's systems and the clomid and Toremifene kick in, product for natural aromatization to estrogen (testosterone)should be available and now the focus is moving towards minimizing estrogen and keep it from going too high as the Test to Est ratio is probably poor. Many subjects have used DHEA throughout post cycle therapy in low doses to potentially aid in maintaining gains through post cycle therapy, but this study was to focus on gyno prevention in already gyno prone rats.
--Daily Fenu caps --------------- weeks 1-5 1/2/2/2/2 (every other day for week 5)
--Daily Oats/Nettle/Ginseng caps- weeks 1-5 1/2/2/2/2 (every other day for week 5 on opposite days of Fenu)
--Clomid----- days 1-4 50mg/day
--Toremifene- days 1-4 90mg/day (Rat nuts back to full size by day 6; other studies state rat nuts back to full size quicker with higher Tore doses)
--Toremifene- days 5-10 60mg/day
--Toremifene- days 11-14 30mg/day
--Nolva------ days 15-18 10mg/day (ALERT! On day 16 test subject showed slight nipple tenderness which for many is the beginning of gyno. 30mg Tore added on days 16 and 17 and Nolva immediately increased to 20mg until day 21. (Presumed cause is tapering down the already low Tore dose too fast combined with underdosing the Nolva when converting from Tore to Nolva)
-1 daily cap of Rebound XT ATD was pulled in and added on day 16 as opposed to the end of post cycle therapy due to pre gyno side effects. All side effects completely resolved by day 18.
--Nolva-- days 16-21 20mg/day
--Nolva-- days 22-28 10mg/day
--RXT--- days 16-28 1 cap/day
Subjects currently in week 5 of post cycle therapy
--Nolva-------- week 5 5mg/day
--RXT--------- week 5 1 cap/every other day
--Fenu-------- week 5 2 caps/every other day.
--Oat complex- week 5 2 caps/every other day on opposite days as fenu.
Current Study Results:
--Gram weight before cycle----------- 165gms (lbs)
--Peak gram weight at end of cycle--- 178gms (lbs)
--Current gram weight at week 5 PCT- 172gms (lbs)
Additional Notes:
--Subject body types: long thin frames, extreme ecto/slight meso, high metabolism and naturally low body fat.
--Subjects diligently given protein shakes before bed every night and upon wakening and always try to maintain positive nitrogen balance during the day and night.
--Subjects have been unable to workout regularly during PCT but have still maintained gains well.